Tomosynthesis Mammographic Imaging Screening Trial (TMIST)

Protocol: 
AAAR5344
Phase: 
III

Tomosynthesis Mammographic Imaging Screening Trial (TMIST)

Are you Eligible? (Inclusion Criteria)

-Patients must be women between 45 and 75 years of age at the time of study
entry.
-Women of childbearing potential must not be pregnant or lactating.
-Patients must be scheduled for, or have intent to schedule, a screening
mammogram.
-Patients must not have symptoms or signs of breast disease.
-Patients must not have had a screening mammogram within the last
11 months prior to date of randomization.

Specialty Area(s)

Trial Location

Herbert Irving Comprehensive Cancer Center
161 Fort Washington Ave.
Herbert Irving Pavilion
New York, NY 10032
United States